Stay updated on Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.
Latest updates to the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
- Check26 days agoChange DetectedThe website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.SummaryDifference3%
- Check41 days agoChange DetectedThe website has added new features for user interaction, while several detailed data fields and options for downloading study information have been removed.SummaryDifference5%
- Check48 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and selecting specific fields, while the previous version v2.12.1 has been removed.SummaryDifference5%
- Check62 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check70 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
Stay in the know with updates to Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in Unresectable Stage III NSCLC Clinical Trial page.